These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3587729)

  • 41. [Urinary tract infections: observations on 19,021 patients hospitalized in Sassari Province].
    Muresu E; Pechmann A; Manca E; Cappai M; Demontis LM; Valca D
    Quad Sclavo Diagn; 1986 Dec; 22(4):369-87. PubMed ID: 3671668
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Sensitivity of bacteria to chemotherapeutic agents (Zurich 1980). Part I. Bacteria isolated from hospital patients].
    Kayser FH; Wüst J; Munzinger J
    Schweiz Med Wochenschr; 1982 Mar; 112(12):411-6. PubMed ID: 7071562
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Microbiology and pharmacology of aztreonam.
    Duma RJ
    Urology; 1988 Jun; 31(6 Suppl):9-13. PubMed ID: 3287750
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aerobic bacteria isolated from blood cultures of patients and their antibiotic susceptibilities in Harare, Zimbabwe.
    Obi CL; Mazarura E
    Cent Afr J Med; 1996 Dec; 42(12):332-6. PubMed ID: 9164012
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In-vitro interactions of FCE 22101 with aminoglycosides against gram-negative rods.
    Said AA; Livermore DM
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():103-8. PubMed ID: 2732132
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro activities of tigecycline combined with other antimicrobials against multiresistant gram-positive and gram-negative pathogens.
    Vouillamoz J; Moreillon P; Giddey M; Entenza JM
    J Antimicrob Chemother; 2008 Feb; 61(2):371-4. PubMed ID: 18033780
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Spectrum of aetiological agents of postoperative endophthalmitis and antibiotic susceptibility of bacterial isolates.
    Anand AR; Therese KL; Madhavan HN
    Indian J Ophthalmol; 2000 Jun; 48(2):123-8. PubMed ID: 11116508
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of automatic antimicrobial susceptibility testing with the MS-2 system.
    Mascellino MT; Prignano G; Lorenzi A; Iegri F; Catania S; Lancia O; Sorice F
    Boll Ist Sieroter Milan; 1984 May; 63(2):104-10. PubMed ID: 6466451
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Imipenem and aztreonam.
    Sobel JD
    Infect Dis Clin North Am; 1989 Sep; 3(3):613-24. PubMed ID: 2671142
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative in vitro activity of carumonam (Ro 17-2301/AMA-1080), a new monobactam, and ceftriaxone against aerobic or facultative gram-negative isolates.
    Barclay CA; Iribarren MA; Goldberg M; Traballi CA; Casellas JM
    Chemotherapy; 1987; 33(3):165-71. PubMed ID: 3595259
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro studies with aztreonam, a new monobactam antibiotic.
    Peddie BA
    N Z Med J; 1986 Apr; 99(799):249. PubMed ID: 3458073
    [No Abstract]   [Full Text] [Related]  

  • 52. Aztreonam in the treatment of gram-negative meningitis in children.
    Isani Z; Rehman N; Adil N; el Messidi M
    Chemioterapia; 1987 Jun; 6(2 Suppl):428-30. PubMed ID: 3334590
    [No Abstract]   [Full Text] [Related]  

  • 53. In vitro antibacterial activity of aztreonam against gram-negative bacilli isolated in 1985.
    Miyake Y; Yokoyama T; Nakano H; Kuwabara M; Yamakido M; Suginaka H
    Hiroshima J Med Sci; 1988 Sep; 37(3):115-7. PubMed ID: 3248945
    [No Abstract]   [Full Text] [Related]  

  • 54. [Aztreonam and aminoglycosides in the therapy of urinary infections associated with renal calculosis].
    Coen G; Nazzaro L; Cipriani P; Giordano A; Mazzaferro S; Petta S; Reale MG; Smacchi A
    Clin Ter; 1989 Feb; 128(4):243-9. PubMed ID: 2524313
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activity of cefotaxime and amikacin against 14,272 gram-negative bacteria from clinical samples in the period 1980 to 1985.
    Dámaso D; Sánchez-Moreno MP; Martínez-Martínez L; Mesa E; Portero F; Mendaza P; Daza RM
    Drugs; 1988; 35 Suppl 2():1-5. PubMed ID: 3396470
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative in vitro activity of ciprofloxacin and other antimicrobial agents against aminoglycoside-resistant gram-negative rods and microorganisms isolated from patients with bacteremia.
    Weinstein MP
    Chemotherapy; 1986; 32(5):446-52. PubMed ID: 3757586
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Susceptibility of clinically isolated strains to aztreonam].
    Daimon Y
    Jpn J Antibiot; 1988 Nov; 41(11):1623-34. PubMed ID: 3145344
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ferric ammonium citrate decomposition--a taxonomic tool for gram-negative bacteria.
    Szentmihályi A; Lányi B
    Acta Microbiol Hung; 1986; 33(1):85-95. PubMed ID: 3529797
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [In vitro activities of aztreonam and sulbactam/ampicillin for gram-negative bacteria].
    Ozkuyumcu C; Durupinar B; Dikmen N
    Mikrobiyol Bul; 1989 Jan; 23(1):77-9. PubMed ID: 2626099
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aztreonam: preclinical studies.
    Bonner DP; Tanaka SK; Schwind RA
    N J Med; 1986 Jan; Spec No():20-5. PubMed ID: 3456495
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.